Retinal pathology in Alzheimer's disease. II. Regional neuron loss and glial changes in GCL
- PMID: 8725900
- DOI: 10.1016/0197-4580(96)00009-7
Retinal pathology in Alzheimer's disease. II. Regional neuron loss and glial changes in GCL
Abstract
Detailed analyses of neuronal and astrocyte cell numbers in the ganglion cell layer (GCL) of whole-mounted peripheral retinas from 16 Alzheimer's disease (AD) and 11 control eyes (11 and 9 cases, respectively) demonstrate extensive neuronal loss throughout the entire retina in AD as compared to control eyes. The observed neuronal loss is most pronounced in the superior and inferior quadrants, ranging between 40 and 49% throughout the midperipheral regions, and reaching 50-59% in the far peripheral inferior retina, while the overall neuronal loss throughout the entire retina amounts to 36.4% (p < 0.004). Although the 16% increase in astrocyte numbers is not significant, the ratio of astrocytes to neurons is significantly higher (82%; p < 0.0008) in AD as compared to normal retina (0.238 +/- 0.070 vs. 0.131 +/- 0.042). These results are strengthened by the close agreement (within +/- 15% of respective means) found between fellow eyes. Analysis of glial fibrillary acidic protein immunoreactivity (GFAP-ir) in sections of retinas from an additional 12 AD and 19 control cases show increased GFAP-ir with more extensive labeling of astrocytes in the GCL as well as increased labeling of Müller cell end-feet and radial processes in AD as compared to control retinas. The extensive loss of neurons documented in these retinas, accompanied by an increased astrocyte/neuron ratio, provides further support for the substantial involvement of the retina in AD.
Similar articles
-
Retinal glial changes in Alzheimer's disease - A review.J Optom. 2019 Jul-Sep;12(3):198-207. doi: 10.1016/j.optom.2018.07.001. Epub 2018 Oct 28. J Optom. 2019. PMID: 30377086 Free PMC article. Review.
-
Retinal pathology in Alzheimer's disease. I. Ganglion cell loss in foveal/parafoveal retina.Neurobiol Aging. 1996 May-Jun;17(3):377-84. doi: 10.1016/0197-4580(96)00010-3. Neurobiol Aging. 1996. PMID: 8725899
-
Idiopathic preretinal glia in aging and age-related macular degeneration.Exp Eye Res. 2016 Sep;150:44-61. doi: 10.1016/j.exer.2015.07.016. Epub 2015 Jul 26. Exp Eye Res. 2016. PMID: 26220834 Free PMC article.
-
Immunohistologic evidence for retinal glial cell changes in human glaucoma.Invest Ophthalmol Vis Sci. 2002 Apr;43(4):1088-94. Invest Ophthalmol Vis Sci. 2002. PMID: 11923250
-
Astrocyte Biomarkers in Alzheimer's Disease.Trends Mol Med. 2019 Feb;25(2):77-95. doi: 10.1016/j.molmed.2018.11.006. Epub 2019 Jan 2. Trends Mol Med. 2019. PMID: 30611668 Review.
Cited by
-
Ganglion cell layer thinning in prodromal Alzheimer's disease defined by amyloid PET.Alzheimers Dement (N Y). 2019 Oct 9;5:570-578. doi: 10.1016/j.trci.2019.08.008. eCollection 2019. Alzheimers Dement (N Y). 2019. PMID: 31650013 Free PMC article.
-
Retinal glial changes in Alzheimer's disease - A review.J Optom. 2019 Jul-Sep;12(3):198-207. doi: 10.1016/j.optom.2018.07.001. Epub 2018 Oct 28. J Optom. 2019. PMID: 30377086 Free PMC article. Review.
-
Detection of Retinal Nerve Fiber Layer Defects in Alzheimer's Disease Using SD-OCT.Front Psychiatry. 2014 Feb 25;5:22. doi: 10.3389/fpsyt.2014.00022. eCollection 2014. Front Psychiatry. 2014. PMID: 24616709 Free PMC article.
-
Early age-related macular degeneration, cognitive function, and dementia: the Cardiovascular Health Study.Arch Ophthalmol. 2009 May;127(5):667-73. doi: 10.1001/archophthalmol.2009.30. Arch Ophthalmol. 2009. PMID: 19433718 Free PMC article.
-
Retinal Functional and Structural Changes in the 5xFAD Mouse Model of Alzheimer's Disease.Front Neurosci. 2020 Aug 13;14:862. doi: 10.3389/fnins.2020.00862. eCollection 2020. Front Neurosci. 2020. PMID: 32903645 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous